The vertically integrated group for cannabinoid-based precision medicine

Qualität, Compliance und Datenschutz als Systemstandard

We operate with clearly defined responsibilities, documented processes, and a strict separation of public and professional information. Data flows and evidence processes are GDPR-compliant, purpose-bound, and governed by established procedures.

Verankert in Exzellenz

Verbunden durch Verantwortung

Our locations form the logical anchor points of a seamless value chain: In Switzerland, we lay the scientific foundation for our innovations through specialized genetics and preclinical research. In Dresden, as our operational center, we transform this foundation into pharmaceutical quality and direct patient care. Strategic global resources ensure the stability and international scalability of our entire system.

Responsibility as a Foundation

People at the center. And evidence that deserves trust.

We believe: Dignity begins with access to reliable medicine. MediFirst builds the structures that translate international research into verifiable quality and traceable care – transparent, evidence-based, and rigorously compliant with regulations. This makes cannabinoid-based precision medicine an option that can be used responsibly and further developed – for healthcare professionals, institutions, and partners.

Ihr nächster Schritt

Whether it's an institutional partnership, a collaboration, or a press inquiry – we forward your requests directly.